World's first tooth-regenerating drug to enter testing in Japan

KYOTO -- A Japanese startup will launch clinical trials in September of what is believed to be the first-ever treatment that can regrow teeth.

Toregem Biopharma aims to bring the antibody drug to market in 2030 for patients missing some or all of their teeth from birth -- a condition known as congenital anodontia. The Kyoto University-affiliated startup hopes to eventually offer it to those who lose teeth later in life as well. It announced the clinical trials Thursday.